- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kathleen Lokay: Clinical Pathways Can Prevent Prior Authorization Delays
Clinical pathways can help providers avoid delays with prior authorization by ensuring that all the necessary information is there, explained Kathleen Lokay, president and CEO of Via Oncology.
Clinical pathways can help providers avoid delays with prior authorization by ensuring that all the necessary information is there, explained Kathleen Lokay, president and CEO of Via Oncology.
Transcript
How can pathways programs assist physicians who face prior authorization delays?
The challenge with prior authorization is the idea that oftentimes what your picking for the patient might be the right thing, but it’s all the information that has to be provided that is necessary to get it paid for. So, it’s rarely that the treatment itself is not eligible for prior authorization, but that the information is lacking.
One of the way we try to support folks with clinical pathways is by providing all that clinical information to the staff who actually seek the prior authorization. By getting the right information into the prior authorization into the portal the first time, then the likelihood of getting the prior authorization and having it go through successfully initially is much higher as opposed to finding out a week or a month or 6 months later that you didn’t give all the information and therefore your prior authorization didn’t go through and you’ve got a denial on your hands.
So that’s one of the key ways we see decision support really helping with prior authorization is by providing that critical clinical data.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
